https://scholars.lib.ntu.edu.tw/handle/123456789/630405
標題: | Outcomes of cancer therapy administered to treatment-naïve lung cancer patients in the intensive care unit | 作者: | YEN-FU CHEN JOU-WEI LIN CHAO-CHI HO CHING-YAO YANG CHIA-HAO CHANG TAO-MIN HUANG CHUNG-YU CHEN KUAN-YU CHEN JIN-YUAN SHIH CHONG-JEN YU |
關鍵字: | Best supportive care; Epidermal growth factor receptor; Intensive care unit; Non-small cell lung cancer; Small cell lung cancer; Treatment-naïve lung cancer; Tyrosine kinase inhibitor | 公開日期: | 2017 | 出版社: | IVYSPRING INT PUBL | 卷: | 8 | 期: | 11 | 起(迄)頁: | 1995 | 來源出版物: | Journal of Cancer | 摘要: | Objectives: Therapy outcomes for newly diagnosed, critically ill lung cancer patients have seldom been evaluated. This study evaluated therapy outcomes for treatment-naïve lung cancer patients in the intensive care unit (ICU). Materials and Methods: Patients were excluded if they had previously received lung cancer treatment, such as systemic chemotherapy, targeted therapy, radiotherapy, or surgical lung resection before ICU admission. The therapeutic strategies for the treatment-naïve patients were determined while they were in the ICU. The patients' demographic data, clinical outcomes, and treatment-related toxicities were analyzed. Results: Newly diagnosed lung cancer patients (n = 72) who did not receive any anticancer treatment before ICU admission were included. Most patients had locally advanced disease, and 61 (84.7%) required intensive care due to cancer-related events. In the ICU, 24 (33.3%) patients received chemotherapy, 24 (33.3%) received epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy and 24 (33.3%) received best supportive care (BSC). Patients receiving chemotherapy or EGFR-TKIs in the ICU demonstrated better ICU (p = 0.011) and in-hospital (p = 0.034) survival than those receiving BSC only. Among patients requiring mechanical ventilation, those receiving chemotherapy had higher weaning rates than those receiving EGFR-TKIs or BSC (p = 0.002). In multivariate analysis, receipt of chemotherapy (hazard ratio [HR], 0.443; p = 0.083) and mechanical ventilation (HR, 0.270; p = 0.022) were significantly associated with longer ICU survival after adjusting for clinical factors. Conclusions: Anticancer therapy in the ICU might provide better short-term ICU survival for treatment-naïve, critically ill lung cancer patients. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630405 | ISSN: | 1837-9664 | DOI: | 10.7150/jca.18178 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。